Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
P. Kierulf. (1973) Studies on Soluble Fibrin in Plasma III. N-Terminal Analysis of a Modified Fraction I (Cohn) from Plasmin- and Thrombin-Incubated Plasma. Scandinavian Journal of Clinical and Laboratory Investigation 31:1, pages 43-49.
Read now
Read now
P. Kierulf. (1973) Studies on Soluble Fibrin in Plasma II. N-Terminal Analysis of a Modified Fraction I (Cohn) from Patient Plasmas. Scandinavian Journal of Clinical and Laboratory Investigation 31:1, pages 37-42.
Read now
Read now
P. Kierulf. (1972) Studies on Soluble Fibrin in Plasma: I a. N-Terminal Analysis of a Modified Fraction I (Cohn) from Plasma Containing Fibrinolytic Inhibitors, and Incubated with Plasminogen-Free Human Thrombin. Scandinavian Journal of Clinical and Laboratory Investigation 29:3, pages 253-257.
Read now
Read now
Articles from other publishers (34)
Berit Grøn, Anne Bennick, Willem Nieuwenhuizen & Frank Brosstad. (1990) Normal and fibrinaemic patient plasma contain high-molecular weight crosslinked fibrin(ogen) derivatives with intact fibrinopeptide A. Thrombosis Research 57:2, pages 259-270.
Crossref
Crossref
O.H. Skjønsberg, Y. Kierulfl, K. Gravem, H. Heistø & H.C. Godal. (1986) Fibrin generation during production of freeze dried antihaemophilic cryoprecipitate. Thrombosis Research 41:3, pages 405-414.
Crossref
Crossref
B. Holm, D.W.T. Nilsen, P. Kierulf & H.C. Godal. (1985) Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thrombosis Research 37:1, pages 165-176.
Crossref
Crossref
P. KIERULF, Å‐B. ANDERSEN & F. BROSSTAD. (2009)
FSF‐stabilized soluble fibrinogen/fibrin intermediates in “Ca
++
‐plasma” at 37 °C
. Scandinavian Journal of Haematology 31:S39, pages 97-102.
Crossref
Crossref
C. Merskey, A.J. Johnson, J. U. Harris, M. T. Wang & S. Swain. (2008) Isolation of Fibrinogen–Fibrin Related Antigen from Human Plasma by Immunoaffinity Chromatography: its Characterization in Normal Subjects and in Defibrinating Patients with Abruptio Placentae and Disseminated Cancer. British Journal of Haematology 44:4, pages 655-670.
Crossref
Crossref
John R. Shainoff & Beatriz N. Dardik. (1980) Role of fibrinogen in fibrin transport: Chromatographic studies. Thrombosis Research 17:3-4, pages 491-500.
Crossref
Crossref
P. Kierulf, F. Brosstad, H.C. Godal, P.K. Lund, A.B. Andersen & I. Næverlid. (1979) Poor discriminating power of fibrinogen-Sepharose towards plasma fibrinogen, fibrin Des-AA and fibrin Des-AABB monomers, as studied by labelled proteins, laser nephelometric fr-antigen and ria-FPA quantitation. Thrombosis Research 16:1-2, pages 1-10.
Crossref
Crossref
F. Brosstad, P. Kierulf & H.C. Godal. (1979) The fibrin-solubilizing effect of fibrinogen as studied by light scattering. Thrombosis Research 14:4-5, pages 705-712.
Crossref
Crossref
F. Brosstad, P. Kierulf, K. Graven & H.C. Godal. (1978) Purification and insolubilization of reptilase for the preparation of human des-AA fibrin monomers in urea. Thrombosis Research 13:5, pages 715-723.
Crossref
Crossref
H. C. Godal, F. Brosstad & P. Kierulf. (2009) Three New Cases of an Inborn Qualitative Fibrinogen Defect (Fibrinogen Oslo II). Scandinavian Journal of Haematology 20:1, pages 57-62.
Crossref
Crossref
M. Kopeć & Z. S. Latallo. 1978. Fibrinolytics and Antifibrinolytics. Fibrinolytics and Antifibrinolytics
81
105
.
R. Reinicke, F.R. Matthias & H.G. Lasch. (1977) Content of soluble fibrin in plasma of patients after myocardial infarction, with carcinomas and consumption coagulopathy. Thrombosis Research 11:3, pages 365-375.
Crossref
Crossref
F. Brosstad. (1977) Purification, characterization and insolubilization of bovine thrombin. Thrombosis Research 11:2, pages 119-130.
Crossref
Crossref
Bengt Gårlund. (1977) Human fibrinogen—immunological properties of the subunits. Immunochemistry 14:6, pages 405-414.
Crossref
Crossref
F.R. Matthias, R. Reinicke & D.L. Heene. (1977) Affinity chromatography and quantitation of soluble fibrin from plasma. Thrombosis Research 10:3, pages 365-384.
Crossref
Crossref
R Anaya-Galindo, S.J Shattil, J.C Shelburne & R.W Colman. (1976) Soluble fibrin complexes in coronary disease. Thrombosis Research 9:2, pages 153-165.
Crossref
Crossref
R. A. Slaastad & H. C. Godal. (2009) Coagulation Profile and the Ethanol Gelation Test with Special Reference to Components Consumed during Coagulation. Scandinavian Journal of Haematology 16:1, pages 25-32.
Crossref
Crossref
Ole Fyrand, Nils Olav Solum & Peter Kierulf. (1976) Heparin precipitable fraction (HPF) from dermatological patients. I. Characterization of the thrombin-clottable protein. Thrombosis Research 8:1, pages 17-29.
Crossref
Crossref
R. A. Slaastad, E. Jakobsen & H. C. Godal. (2009) A Positive Ethanol Gelation Test Associated with High Plasma Fibrinogen Concentration ‐Evidence for Soluble Fibrin. Scandinavian Journal of Haematology 15:3, pages 192-200.
Crossref
Crossref
R. A. Slaastad, H. C. Godal & P. Kierulf. (2009) The Amount of Fibrin Necessary to Give a Positive Ethanol Gelation Test at Various Fibrinogen Levels. Scandinavian Journal of Haematology 15:2, pages 153-160.
Crossref
Crossref
Bernt Ly & Peter Kierulf. (1975) Radioiodinated human fibrinogen. In vitro effects of increasing iodination. Thrombosis Research 6:5, pages 387-398.
Crossref
Crossref
Bernt Ly, Peter Kierulf & Harald Arnesan. (1974) Molecular aspects of the clottable proteins of human plasma during fibrinogenolysis. Thrombosis Research 5:3, pages 301-314.
Crossref
Crossref
Bernt Ly, Peter Kierulf, Erling Jakobsen & Karl Gravem. (1974) Characterization of soluble, FSF-stabilized fibrin complexes with special reference to the role of fibrinogen. Thrombosis Research 5:1, pages 21-32.
Crossref
Crossref
Robert Wetmore & Victor Gurewich. (2009) The Role of Fibrin Monomer and an in vivo Thrombin‐Induced Anticoagulant in Experimental Venous Thrombosis. Scandinavian Journal of Haematology 12:3, pages 204-212.
Crossref
Crossref
Harald Arnesen. (2009) The Effect of Products D and E on the Thrombin Induced Conversion of Fibrinogen to Fibrin. Scandinavian Journal of Haematology 12:3, pages 165-172.
Crossref
Crossref
Peter Kierulf. (1974) Studies on soluble fibrin in plasma V. Isolation and characterization of the clottable proteins obtained from patient plasmas upon gelation with ethanol. Thrombosis Research 4:1, pages 183-187.
Crossref
Crossref
J. F. BergmannF. R. Matthias, D. L. Heene & R. Reinicke. 1974. Achtzigster Kongress. Achtzigster Kongress
1456
1458
.
Peter Kierulf. (1973) Studies on soluble fibrin in plasma IV: Isolation and characterization of the clottable proteins obtained from thrombin incubated plasma upon gelation with ethanol. Thrombosis Research 3:6, pages 613-620.
Crossref
Crossref
Harald Arnesen, Peter Kierulf & Hans Chr. Godal. (2009) The Influence of Fibrinogen Degradation Products on the Reptilase‐Time of Plasma. Scandinavian Journal of Haematology 11:5, pages 360-366.
Crossref
Crossref
E. Jakobsen & P. Kierulf. (1973) A modified beta-alanine precipitation procedure to prepare fibrinogen free of antithrombin-III and plasminogen. Thrombosis Research 3:2, pages 145-159.
Crossref
Crossref
Harald Arnesen & Hans Chr. Godal. (2009) Studies on the Thrombin Clotting Time. Scandinavian Journal of Haematology 10:3, pages 232-240.
Crossref
Crossref
H.C. Godal, C. Eika & P. Kierulf. (1973) Liquoid, a weak anticoagulant with strong “procoagulant” properties as compared with heparin. Thrombosis Research 2:2, pages 155-171.
Crossref
Crossref
Peter Kierulf. (1972) N-terminal analysis of ‘fibrins’ from plasmin hydrolysed fibrinogen - evidence for lack of fibrinopeptide B. Thrombosis Research 1:5, pages 527-532.
Crossref
Crossref
P. KIERULF & H. C. GODAL. (2009) Fibrinaemia and Multiple Thrombi in Pancreatic Carcinoma: A Case Studied with Quantitative N-Terminal Analysis. Scandinavian Journal of Haematology 9:1-6, pages 370-376.
Crossref
Crossref